Natalizumab-Induced Pustular Psoriasis of Palms and Soles

Natalizumab-Induced Pustular Psoriasis of Palms and Soles

Authors

  • Bengisu Ozarslan Dermatology Unit, Doku Medical Center, Istanbul, Turkey
  • Teresa Russo Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy
  • Giuseppe Argenziano Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy
  • Vincenzo Piccolo Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy

Keywords:

natalizumab, psoriasis, pustular, palmoplantar

References

Kwok T, Loo WJ, Guenther L. Psoriasis and multiple sclerosis: is there a link? J Cutan Med Surg. 2010;14(4):151-155. DOIi: 10.2310/7750.2010.09063. PMID: 20642982.

Lambrianides S, Kinnis E, Leonidou E, Pantzaris M. Does natalizumab induce or aggravate psoriasis? A case study and review of the literature. Case Rep Neurol. 201818;10(3):286-291. DOI: 10.1159/000492891. PMID: 30323758. PMCID: PMC6180259.

Downloads

Published

2022-05-02

Issue

2022 Vol 12, No 2 | April

Section

Research Letter

License

Copyright (c) 2022 Bengisu Ozarslan, Teresa Russo, Giuseppe Argenziano, Vincenzo Piccolo

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

How to Cite

1.
Ozarslan B, Russo T, Argenziano G, Piccolo V. Natalizumab-Induced Pustular Psoriasis of Palms and Soles. Dermatol Pract Concept. 2022;12(2):e2022088. doi:10.5826/dpc.1202a88

Share

Crossref
Scopus
Google Scholar
Europe PMC